Radboud University Medical Center: Atherosclerosis trials

The registry lists 13 Atherosclerosis studies with Radboud University Medical Center as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 4 4No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)Enrolling by invitationNCT07625488
• The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)Enrolling by invitationNCT06083155
• Time Restricted Eating and Innate ImmunityCompletedNCT05639244Not applicable
• Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 AntibodyCompletedNCT04141579Not applicable
• The Effect of Statin Treatment on Trained Innate ImmunityCompletedNCT03354156
• The Role of Stem Cells on Immune Cells in the Development of Cardiovascular DiseasesCompletedNCT03172507
• Effect of Statins on Trained ImmunityCompletedNCT02817230
• Epigenetic Reprogramming of Monocytes in Patients With Coronary AtherosclerosisCompletedNCT02393768
• Evaluation of Non-invasive Measurements of Atherosclerosis in Cardiovascular Risk StratificationCompletedNCT01555294
• Heme Oxygenase (HO) Activity and Adenosine Induced VasodilationTerminatedNCT00856817Phase 4
• Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?CompletedNCT00851175Phase 4
• Persantin Preceding Elective PCICompletedNCT00767663Phase 4
• Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?CompletedNCT00457405Phase 4